CRISPR-mediated correction of oncogenic AS-NMD in splicing factor mutant cancer.

Nagar P, Islam MR, Rahman NA, Heeamoni SA, Hasan MM, Huq S, Bushra FA, Hu M, Ali R, Hossain M, Rahman MA

DOI: 10.3389/fimmu.2026.1958532
Published: 2026
Container: Frontiers in immunology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1958532,
  title = {CRISPR-mediated correction of oncogenic AS-NMD in splicing factor mutant cancer.},
  author = {Nagar P and Islam MR and Rahman NA and Heeamoni SA and Hasan MM and Huq S and Bushra FA and Hu M and Ali R and Hossain M and Rahman MA},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1958532},
  url = {https://doi.org/10.3389/fimmu.2026.1958532}
}

RIS

TY  - JOUR
TI  - CRISPR-mediated correction of oncogenic AS-NMD in splicing factor mutant cancer.
AU  - Nagar P
AU  - Islam MR
AU  - Rahman NA
AU  - Heeamoni SA
AU  - Hasan MM
AU  - Huq S
AU  - Bushra FA
AU  - Hu M
AU  - Ali R
AU  - Hossain M
AU  - Rahman MA
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1958532
UR  - https://doi.org/10.3389/fimmu.2026.1958532
ER  -

APA

P, N., MR, I., NA, R., SA, H., MM, H., S, H., FA, B., M, H., R, A., M, H., & MA, R. (2026). CRISPR-mediated correction of oncogenic AS-NMD in splicing factor mutant cancer.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1958532

Source records

pubmed · retrieved 2026-11-10T05:32:59.748Z